The Asia Pacific sarcopenia treatment market was valued at US$ 696.85 million in 2022 and is expected to reach US$ 1.16 billion by 2030; it is estimated to register a CAGR of 6.6% from 2022 to 2030.
Products in Clinical Trial Phases Drive Asia Pacific Sarcopenia Treatment Market
A few major players operating in the sarcopenia treatment market are increasingly focusing on drug development to treat sarcopenia. Novel sarcopenia treatments are currently being developed and tested in clinical trials. A few of these products are mentioned below:
Table 1. Sarcopenia Drug Under Clinical Development
Company Name Interventions Conditions Clinical Trial Stage
Therefore, the extending pipeline of drugs that are in different stages of clinical development presents significant opportunities for the sarcopenia treatment market growth.
Asia Pacific Sarcopenia Treatment Market Overview
The Asia Pacific sarcopenia treatment market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. Asia Pacific is expected to register the fastest CAGR in the global market during the forecast period. Asia is the world's most populated continent with a rapidly aging population, and sarcopenia-related issues are becoming more prevalent in several Asian countries. Asians led extremely different lifestyles and follow different dietary habits than people from the Western world. In Asia, sarcopenia in older individuals is more common in males (prevalence 9.6-22.1%) than females (prevalence 7.7-21.8%). Asian Working Group for Sarcopenia (AWGS) aims to promote sarcopenia research in Asia.
Asia Pacific Sarcopenia Treatment Market Segmentation
The Asia Pacific sarcopenia treatment market is categorized into treatment type, distribution channel, and country.
Based on treatment type, the Asia Pacific sarcopenia treatment market is segmented into vitamin D and calcium supplement, protein supplement, vitamin B12 supplement, and others. The vitamin D and calcium supplement segment held the largest Asia Pacific sarcopenia treatment market share in 2022.
In terms of distribution channel, the Asia Pacific sarcopenia treatment market is segmented into pharmacies, retail channels, online channels, and others. The pharmacies segment held the largest Asia Pacific sarcopenia treatment market share in 2022.
By country, the Asia Pacific sarcopenia treatment market is segmented into China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific sarcopenia treatment market share in 2022.
Abbott Laboratories, Bayer AG, Metagenics LLC, Nestle Health Science SA, Novartis AG, Pfizer Inc, Sanofi SA, Amway Corp, and GSK Plc are some of the leading companies operating in the Asia Pacific sarcopenia treatment market.
Table of Contents
1. Introduction
1.1 Research Report Guidance 1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage 3.2 Secondary Research 3.3 Primary Research
4. Asia Pacific Sarcopenia Treatment Market - Key Industry Dynamics
4.1 Asia Pacific Sarcopenia Treatment Market - Key Industry Dynamics 4.2 Market Drivers 4.2.1 Upsurge in Geriatric Population 4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults 4.3 Key Market Restraints: 4.3.1 Unavailability of Direct Interventions 4.4 Key Market Opportunities: 4.4.1 Products in Clinical Trial Phases 4.5 Future Trends: 4.5.1 Rising Awareness About Sarcopenia 4.6 Impact of Drivers and Restraints:
5. Sarcopenia Treatment Market - Asia Pacific Market Analysis
5.1 Asia Pacific Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030 5.2 Asia Pacific Sarcopenia Treatment Market Forecast and Analysis
6. Asia Pacific Sarcopenia Treatment Market Analysis - By Treatment Type
6.1 Vitamin D and Calcium Supplement 6.1.1 Overview 6.1.2 Vitamin D and Calcium Supplement: Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million) 6.2 Protein Supplement 6.2.1 Overview 6.2.2 Protein Supplement : Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million) 6.3 Vitamin B12 Supplement 6.3.1 Overview 6.3.2 Vitamin B12 Supplement: Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million) 6.4 Others 6.4.1 Overview 6.4.2 Others : Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Sarcopenia Treatment Market Analysis - By Distribution Channel
7.1 Pharmacies 7.1.1 Overview 7.1.2 Pharmacies : Asia Pacific Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million) 7.2 Retail Channels 7.2.1 Overview 7.2.2 Retail Channels : Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million) 7.3 Online Channels 7.3.1 Overview 7.3.2 Online Channels : Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million) 7.4 Others 7.4.1 Overview 7.4.2 Others : Asia Pacific Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Sarcopenia Treatment Market - Country Analysis
8.1 Asia Pacific 8.1.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country 8.1.1.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country 8.1.1.2 China Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn) 8.1.1.2.1 China Sarcopenia Treatment Market Breakdown by Treatment Type 8.1.1.2.2 China Sarcopenia Treatment Market Breakdown by Distribution Channel 8.1.1.3 India Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn) 8.1.1.3.1 India Sarcopenia Treatment Market Breakdown by Treatment Type 8.1.1.3.2 India Sarcopenia Treatment Market Breakdown by Distribution Channel 8.1.1.4 Japan Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn) 8.1.1.4.1 Japan Sarcopenia Treatment Market Breakdown by Treatment Type 8.1.1.4.2 Japan Sarcopenia Treatment Market Breakdown by Distribution Channel 8.1.1.5 South Korea Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn) 8.1.1.5.1 South Korea Sarcopenia Treatment Market Breakdown by Treatment Type 8.1.1.5.2 South Korea Sarcopenia Treatment Market Breakdown by Distribution Channel 8.1.1.6 Australia Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn) 8.1.1.6.1 Australia Sarcopenia Treatment Market Breakdown by Treatment Type 8.1.1.6.2 Australia Sarcopenia Treatment Market Breakdown by Distribution Channel 8.1.1.7 Rest of Asia Pacific Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn) 8.1.1.7.1 Rest of Asia Pacific Sarcopenia Treatment Market Breakdown by Treatment Type 8.1.1.7.2 Rest of Asia Pacific Sarcopenia Treatment Market Breakdown by Distribution Channel
10.1 Abbott Laboratories 10.1.1 Key Facts 10.1.2 Business Description 10.1.3 Products and Services 10.1.4 Financial Overview 10.1.5 SWOT Analysis 10.1.6 Key Developments 10.2 Bayer AG 10.2.1 Key Facts 10.2.2 Business Description 10.2.3 Products and Services 10.2.4 Financial Overview 10.2.5 SWOT Analysis 10.2.6 Key Developments 10.3 Metagenics LLC 10.3.1 Key Facts 10.3.2 Business Description 10.3.3 Products and Services 10.3.4 Financial Overview 10.3.5 SWOT Analysis 10.3.6 Key Developments 10.4 Nestle Health Science SA 10.4.1 Key Facts 10.4.2 Business Description 10.4.3 Products and Services 10.4.4 Financial Overview 10.4.5 SWOT Analysis 10.4.6 Key Developments 10.5 Novartis AG 10.5.1 Key Facts 10.5.2 Business Description 10.5.3 Products and Services 10.5.4 Financial Overview 10.5.5 SWOT Analysis 10.5.6 Key Developments 10.6 Pfizer Inc 10.6.1 Key Facts 10.6.2 Business Description 10.6.3 Products and Services 10.6.4 Financial Overview 10.6.5 SWOT Analysis 10.6.6 Key Developments 10.7 Sanofi SA 10.7.1 Key Facts 10.7.2 Business Description 10.7.3 Products and Services 10.7.4 Financial Overview 10.7.5 SWOT Analysis 10.7.6 Key Developments 10.8 Amway Corp 10.8.1 Key Facts 10.8.2 Business Description 10.8.3 Products and Services 10.8.4 Financial Overview 10.8.5 SWOT Analysis 10.8.6 Key Developments 10.9 GSK Plc 10.9.1 Key Facts 10.9.2 Business Description 10.9.3 Products and Services 10.9.4 Financial Overview 10.9.5 SWOT Analysis 10.9.6 Key Developments
11. Appendix
11.1 About The Publisher 11.2 Glossary of Terms LIST OF TABLES Table 1. Asia Pacific Sarcopenia Treatment Market Segmentation Table 2. Sarcopenia Drug Under Clinical Development Table 3. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) Table 4. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Treatment Type Table 5. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel Table 6. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country Table 7. China Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type Table 8. China Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel Table 9. India Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type Table 10. India Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel Table 11. Japan Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type Table 12. Japan Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel Table 13. South Korea Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type Table 14. South Korea Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel Table 15. Australia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type Table 16. Australia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel Table 17. Rest of Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type Table 18. Rest of Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel Table 19. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market Table 20. Recent Organic Growth Strategies in the Sarcopenia Treatment Market Table 21. Glossary of Terms, Sarcopenia Treatment Market LIST OF FIGURES Figure 1. Asia Pacific Sarcopenia Treatment Market Segmentation, By Country Figure 2. Impact Analysis of Drivers and Restraints Figure 3. Asia Pacific Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030 Figure 4. Asia Pacific Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030 Figure 5. Vitamin D and Calcium Supplement: Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million) Figure 6. Protein Supplement : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million) Figure 7. Vitamin B12 Supplement: Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million) Figure 8. Others : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million) Figure 9. Asia Pacific Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030 Figure 10. Pharmacies : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million) Figure 11. Retail Channels : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million) Figure 12. Online Channels : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million) Figure 13. Others : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million) Figure 14. Asia Pacific Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn) Figure 15. Asia Pacific Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%) Figure 16. China Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) Figure 17. India Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) Figure 18. Japan Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) Figure 19. South Korea Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) Figure 20. Australia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) Figure 21. Rest of Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) Figure 22. Growth Strategies in the Sarcopenia Treatment Market
The Sarcopenia Drug market is a subset of the Musculoskeletal Disorders Drugs market, which focuses on the treatment of age-related muscle loss. Sarcopenia is a condition that affects older adults, causing a decrease in muscle mass, strength, and physical performance. Drugs used to treat sarcopenia are typically anabolic agents, such as testosterone, growth hormone, and selective androgen receptor modulators. These drugs are used to increase muscle mass and strength, as well as improve physical performance.
The Sarcopenia Drug market is expected to grow in the coming years due to the increasing prevalence of sarcopenia and the growing elderly population. Additionally, the development of new drugs and treatments for sarcopenia is expected to drive the market.
Some companies in the Sarcopenia Drug market include Pfizer, Merck, Novartis, Eli Lilly, and AbbVie. Show Less Read more
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is a site license, allowing all users within a given geographical location of your organization access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF.